Off-label DOAC Dosing Common in Hospitalized AF Patients, Too

There remains room for improvement, despite a decline in use of nonrecommended dosing over time, a researcher says.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,American ,Ramneet Sandhu ,Bayer Janssen ,Boehringer Ingelheim ,Md University Of Colorado Hospital ,Bristol Myers Squibb ,American Heart Association ,Colorado Hospital ,Cardiovascular Quality ,With The Guidelines ,Get With The Guidelines ,